Mark Adrian Luscher Sells 70,750 Shares of Microbix Biosystems Inc. (TSE:MBX) Stock

Microbix Biosystems Inc. (TSE:MBX) Senior Officer Mark Adrian Luscher sold 70,750 shares of the company’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of C$0.43, for a total value of C$30,295.15.

Mark Adrian Luscher also recently made the following trade(s):

• On Thursday, February 27th, Mark Adrian Luscher sold 6,000 shares of Microbix Biosystems stock. The stock was sold at an average price of C$0.45, for a total value of C$2,700.00.

Microbix Biosystems Price Performance

TSE MBX traded down C$0.01 on Monday, reaching C$0.44. The company’s stock had a trading volume of 159,793 shares, compared to its average volume of 205,992. Microbix Biosystems Inc. has a twelve month low of C$0.29 and a twelve month high of C$0.55. The company has a debt-to-equity ratio of 22.61, a quick ratio of 5.57 and a current ratio of 7.15. The firm’s 50 day moving average is C$0.46 and its two-hundred day moving average is C$0.38. The stock has a market cap of C$57.29 million, a PE ratio of 16.57 and a beta of 0.34.

Microbix Biosystems Company Profile

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.